Maria Inmaculada
Heras Fernando
Asociado Ciencias de la Salud
Cristina
Castilla Llorente
Publicaciones en las que colabora con Cristina Castilla Llorente (8)
2019
-
Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma
Biology of Blood and Marrow Transplantation, Vol. 25, Núm. 9, pp. 1703-1712
2018
-
Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation
Hematology, Vol. 23, Núm. 9, pp. 712-718
-
Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution
Blood Transfusion, Vol. 16, Núm. 3, pp. 273-278
2016
-
Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience
Bone Marrow Transplantation, Vol. 51, Núm. 10, pp. 1307-1312
-
Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: Kinetics, clinical impact and absence of STAT3 mutations
British Journal of Haematology, Vol. 172, Núm. 6, pp. 937-946
2015
-
Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: Improving outcomes over time
Bone Marrow Transplantation, Vol. 50, Núm. 2, pp. 274-281
2013
-
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients
British Journal of Haematology, Vol. 162, Núm. 4, pp. 474-482